Evidence map›Paper›PMID 40674356›Full record

ArticleJournal of proteome research2025

Activating Cancer Hallmarks through Changes in mRNA/Protein Regulation.

Jose Humberto Giraldez Chavez, Nathaniel Barton, Caleb M Lindgren, Bryn Mendenhall, Benjamin Kimball, Samuel H Payne

Abstract read
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jose Humberto Giraldez ChavezBiology Department, Brigham Young University, Provo, Utah 84602, United States.
Nathaniel BartonBiology Department, Brigham Young University, Provo, Utah 84602, United States.ORCID 0000-0002-0383-7741
Caleb M LindgrenBiology Department, Brigham Young University, Provo, Utah 84602, United States.ORCID 0000-0001-6484-9757
Bryn MendenhallBiology Department, Brigham Young University, Provo, Utah 84602, United States.
Benjamin KimballBiology Department, Brigham Young University, Provo, Utah 84602, United States.
Samuel H PayneBiology Department, Brigham Young University, Provo, Utah 84602, United States.ORCID 0000-0002-8351-1994

Funding

Proteogenomic Data Analysis for Cancer Systems Biology and Clinical TranslationU24CA210972 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DING, LI, FENYO, DAVID · 2016 to 2020
$3.3M
NCI NIH HHS U24 CA210972
6 · The paper itself

Abstract

As a diverse family of diseases, cancer is unified by a set of common dysfunctions, such as limitless growth potential and an insensitivity to antigrowth signals. These shared overarching biological processes have been termed the hallmarks of cancer. To better understand the root cause of cellular dysregulation, intense molecular characterization of tumors has utilized DNA, RNA, and protein measurement techniques to produce proteogenomic data. In large cancer cohort studies, genomic and proteogenomic data have frequently identified many cancer hallmarks including cell cycle and cell signaling. However, altered metabolism, a known cancer hallmark, is not as clearly identified in mutation screens or differential expression analyses. Here, we introduce a new computational method to identify changes in cellular regulation by focusing on the mRNA/protein relationship. We create a metric, Δ_corr, to capture when the mRNA/protein correlation changes significantly between tumor and normal tissues and show that it is distinct from differential expression and also not associated with DNA mutation profiles. Our method clearly highlights altered metabolic pathways across multiple tumor types. Δ_corr gives researchers a new perspective on the dysfunction of tumor cells and introduces a novel method for proteogenomic data integration.

Indexed as

Gene Expression Regulation, NeoplasticNeoplasmsRNA, MessengerHumansMutationProteogenomicsRNA, Messengerbioinformaticscancerdata analysismultiomicsproteogenomics

Identifiers

PMID40674356
PMCPMC12322998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.